Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Allergan Bats Its Eyes At Consumers With Latisse Marketing Campaign

Executive Summary

Allergan is charting new territory in marketing its eyelash growth stimulant Latisse, a product with a purely aesthetic indication that will be uniquely consumer-driven

You may also be interested in...



Fibrocell's Wrinkle Drug Underlines Challenges Of Seeking Aesthetic Claims

An FDA advisory committee made very clear that the bar should be much higher for novel products proposed for aesthetic indications than for drugs to treat diseases during the Oct. 9 review of Fibrocell Science's wrinkle therapy Laviv (azfibrocel-T)

Fibrocell's Wrinkle Drug Underlines Challenges Of Seeking Aesthetic Claims

An FDA advisory committee made very clear that the bar should be much higher for novel products proposed for aesthetic indications than for drugs to treat diseases during the Oct. 9 review of Fibrocell Science's wrinkle therapy Laviv (azfibrocel-T)

Allergan Adapts Trial Design; Latisse Endpoints Based On Consumer Feedback

The clinical trial endpoints for Allergan's eyelash stimulant drug, Latisse, were determined through discussions with consumer panels about what was most desired in a drug that enhances eyelashes

Related Content

Topics

UsernamePublicRestriction

Register

PS050517

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel